Anti-AIDs Drug Market, Global Outlook and Forecast 2022-2028

March 2022 | 75 pages | ID: A62A60F3A348EN
Market Monitor Global

Abstracts

This report contains market size and forecasts of Anti-AIDs Drug in global, including the following market information:

Global Anti-AIDs Drug Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global Anti-AIDs Drug Market Sales, 2017-2022, 2023-2028, (K Doses)

Global top five Anti-AIDs Drug companies in 2021 (%)

The global Anti-AIDs Drug market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Prescription Drugs Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Anti-AIDs Drug include GSK, Cipla, MSD, Gilead Sciences and Frontier Biotechnologies, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Anti-AIDs Drug manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Anti-AIDs Drug Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Doses)

Global Anti-AIDs Drug Market Segment Percentages, by Type, 2021 (%)

• Prescription Drugs
• Non-prescription Drugs

Global Anti-AIDs Drug Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Doses)

Global Anti-AIDs Drug Market Segment Percentages, by Application, 2021 (%)

• Pharmacy
• Hospital

Global Anti-AIDs Drug Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Doses)

Global Anti-AIDs Drug Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Anti-AIDs Drug revenues in global market, 2017-2022 (Estimated), ($ millions)

Key companies Anti-AIDs Drug revenues share in global market, 2021 (%)

Key companies Anti-AIDs Drug sales in global market, 2017-2022 (Estimated), (K Doses)

Key companies Anti-AIDs Drug sales share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• GSK
• Cipla
• MSD
• Gilead Sciences
• Frontier Biotechnologies

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Anti-AIDs Drug Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Anti-AIDs Drug Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL ANTI-AIDS DRUG OVERALL MARKET SIZE

2.1 Global Anti-AIDs Drug Market Size: 2021 VS 2028
2.2 Global Anti-AIDs Drug Revenue, Prospects & Forecasts: 2017-2028
2.3 Global Anti-AIDs Drug Sales: 2017-2028

3 COMPANY LANDSCAPE

3.1 Top Anti-AIDs Drug Players in Global Market
3.2 Top Global Anti-AIDs Drug Companies Ranked by Revenue
3.3 Global Anti-AIDs Drug Revenue by Companies
3.4 Global Anti-AIDs Drug Sales by Companies
3.5 Global Anti-AIDs Drug Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 Anti-AIDs Drug Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers Anti-AIDs Drug Product Type
3.8 Tier 1, Tier 2 and Tier 3 Anti-AIDs Drug Players in Global Market
  3.8.1 List of Global Tier 1 Anti-AIDs Drug Companies
  3.8.2 List of Global Tier 2 and Tier 3 Anti-AIDs Drug Companies

4 SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 By Type - Global Anti-AIDs Drug Market Size Markets, 2021 & 2028
  4.1.2 Prescription Drugs
  4.1.3 Non-prescription Drugs
4.2 By Type - Global Anti-AIDs Drug Revenue & Forecasts
  4.2.1 By Type - Global Anti-AIDs Drug Revenue, 2017-2022
  4.2.2 By Type - Global Anti-AIDs Drug Revenue, 2023-2028
  4.2.3 By Type - Global Anti-AIDs Drug Revenue Market Share, 2017-2028
4.3 By Type - Global Anti-AIDs Drug Sales & Forecasts
  4.3.1 By Type - Global Anti-AIDs Drug Sales, 2017-2022
  4.3.2 By Type - Global Anti-AIDs Drug Sales, 2023-2028
  4.3.3 By Type - Global Anti-AIDs Drug Sales Market Share, 2017-2028
4.4 By Type - Global Anti-AIDs Drug Price (Manufacturers Selling Prices), 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Anti-AIDs Drug Market Size, 2021 & 2028
  5.1.2 Pharmacy
  5.1.3 Hospital
5.2 By Application - Global Anti-AIDs Drug Revenue & Forecasts
  5.2.1 By Application - Global Anti-AIDs Drug Revenue, 2017-2022
  5.2.2 By Application - Global Anti-AIDs Drug Revenue, 2023-2028
  5.2.3 By Application - Global Anti-AIDs Drug Revenue Market Share, 2017-2028
5.3 By Application - Global Anti-AIDs Drug Sales & Forecasts
  5.3.1 By Application - Global Anti-AIDs Drug Sales, 2017-2022
  5.3.2 By Application - Global Anti-AIDs Drug Sales, 2023-2028
  5.3.3 By Application - Global Anti-AIDs Drug Sales Market Share, 2017-2028
5.4 By Application - Global Anti-AIDs Drug Price (Manufacturers Selling Prices), 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Anti-AIDs Drug Market Size, 2021 & 2028
6.2 By Region - Global Anti-AIDs Drug Revenue & Forecasts
  6.2.1 By Region - Global Anti-AIDs Drug Revenue, 2017-2022
  6.2.2 By Region - Global Anti-AIDs Drug Revenue, 2023-2028
  6.2.3 By Region - Global Anti-AIDs Drug Revenue Market Share, 2017-2028
6.3 By Region - Global Anti-AIDs Drug Sales & Forecasts
  6.3.1 By Region - Global Anti-AIDs Drug Sales, 2017-2022
  6.3.2 By Region - Global Anti-AIDs Drug Sales, 2023-2028
  6.3.3 By Region - Global Anti-AIDs Drug Sales Market Share, 2017-2028
6.4 North America
  6.4.1 By Country - North America Anti-AIDs Drug Revenue, 2017-2028
  6.4.2 By Country - North America Anti-AIDs Drug Sales, 2017-2028
  6.4.3 US Anti-AIDs Drug Market Size, 2017-2028
  6.4.4 Canada Anti-AIDs Drug Market Size, 2017-2028
  6.4.5 Mexico Anti-AIDs Drug Market Size, 2017-2028
6.5 Europe
  6.5.1 By Country - Europe Anti-AIDs Drug Revenue, 2017-2028
  6.5.2 By Country - Europe Anti-AIDs Drug Sales, 2017-2028
  6.5.3 Germany Anti-AIDs Drug Market Size, 2017-2028
  6.5.4 France Anti-AIDs Drug Market Size, 2017-2028
  6.5.5 U.K. Anti-AIDs Drug Market Size, 2017-2028
  6.5.6 Italy Anti-AIDs Drug Market Size, 2017-2028
  6.5.7 Russia Anti-AIDs Drug Market Size, 2017-2028
  6.5.8 Nordic Countries Anti-AIDs Drug Market Size, 2017-2028
  6.5.9 Benelux Anti-AIDs Drug Market Size, 2017-2028
6.6 Asia
  6.6.1 By Region - Asia Anti-AIDs Drug Revenue, 2017-2028
  6.6.2 By Region - Asia Anti-AIDs Drug Sales, 2017-2028
  6.6.3 China Anti-AIDs Drug Market Size, 2017-2028
  6.6.4 Japan Anti-AIDs Drug Market Size, 2017-2028
  6.6.5 South Korea Anti-AIDs Drug Market Size, 2017-2028
  6.6.6 Southeast Asia Anti-AIDs Drug Market Size, 2017-2028
  6.6.7 India Anti-AIDs Drug Market Size, 2017-2028
6.7 South America
  6.7.1 By Country - South America Anti-AIDs Drug Revenue, 2017-2028
  6.7.2 By Country - South America Anti-AIDs Drug Sales, 2017-2028
  6.7.3 Brazil Anti-AIDs Drug Market Size, 2017-2028
  6.7.4 Argentina Anti-AIDs Drug Market Size, 2017-2028
6.8 Middle East & Africa
  6.8.1 By Country - Middle East & Africa Anti-AIDs Drug Revenue, 2017-2028
  6.8.2 By Country - Middle East & Africa Anti-AIDs Drug Sales, 2017-2028
  6.8.3 Turkey Anti-AIDs Drug Market Size, 2017-2028
  6.8.4 Israel Anti-AIDs Drug Market Size, 2017-2028
  6.8.5 Saudi Arabia Anti-AIDs Drug Market Size, 2017-2028
  6.8.6 UAE Anti-AIDs Drug Market Size, 2017-2028

7 MANUFACTURERS & BRANDS PROFILES

7.1 GSK
  7.1.1 GSK Corporate Summary
  7.1.2 GSK Business Overview
  7.1.3 GSK Anti-AIDs Drug Major Product Offerings
  7.1.4 GSK Anti-AIDs Drug Sales and Revenue in Global (2017-2022)
  7.1.5 GSK Key News
7.2 Cipla
  7.2.1 Cipla Corporate Summary
  7.2.2 Cipla Business Overview
  7.2.3 Cipla Anti-AIDs Drug Major Product Offerings
  7.2.4 Cipla Anti-AIDs Drug Sales and Revenue in Global (2017-2022)
  7.2.5 Cipla Key News
7.3 MSD
  7.3.1 MSD Corporate Summary
  7.3.2 MSD Business Overview
  7.3.3 MSD Anti-AIDs Drug Major Product Offerings
  7.3.4 MSD Anti-AIDs Drug Sales and Revenue in Global (2017-2022)
  7.3.5 MSD Key News
7.4 Gilead Sciences
  7.4.1 Gilead Sciences Corporate Summary
  7.4.2 Gilead Sciences Business Overview
  7.4.3 Gilead Sciences Anti-AIDs Drug Major Product Offerings
  7.4.4 Gilead Sciences Anti-AIDs Drug Sales and Revenue in Global (2017-2022)
  7.4.5 Gilead Sciences Key News
7.5 Frontier Biotechnologies
  7.5.1 Frontier Biotechnologies Corporate Summary
  7.5.2 Frontier Biotechnologies Business Overview
  7.5.3 Frontier Biotechnologies Anti-AIDs Drug Major Product Offerings
  7.5.4 Frontier Biotechnologies Anti-AIDs Drug Sales and Revenue in Global (2017-2022)
  7.5.5 Frontier Biotechnologies Key News

8 GLOBAL ANTI-AIDS DRUG PRODUCTION CAPACITY, ANALYSIS

8.1 Global Anti-AIDs Drug Production Capacity, 2017-2028
8.2 Anti-AIDs Drug Production Capacity of Key Manufacturers in Global Market
8.3 Global Anti-AIDs Drug Production by Region

9 KEY MARKET TRENDS, OPPORTUNITY, DRIVERS AND RESTRAINTS

9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints

10 ANTI-AIDS DRUG SUPPLY CHAIN ANALYSIS

10.1 Anti-AIDs Drug Industry Value Chain
10.2 Anti-AIDs Drug Upstream Market
10.3 Anti-AIDs Drug Downstream and Clients
10.4 Marketing Channels Analysis
  10.4.1 Marketing Channels
  10.4.2 Anti-AIDs Drug Distributors and Sales Agents in Global

11 CONCLUSION

12 APPENDIX

12.1 Note
12.2 Examples of Clients
12.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Key Players of Anti-AIDs Drug in Global Market
Table 2. Top Anti-AIDs Drug Players in Global Market, Ranking by Revenue (2021)
Table 3. Global Anti-AIDs Drug Revenue by Companies, (US$, Mn), 2017-2022
Table 4. Global Anti-AIDs Drug Revenue Share by Companies, 2017-2022
Table 5. Global Anti-AIDs Drug Sales by Companies, (K Doses), 2017-2022
Table 6. Global Anti-AIDs Drug Sales Share by Companies, 2017-2022
Table 7. Key Manufacturers Anti-AIDs Drug Price (2017-2022) & (USD/Dose)
Table 8. Global Manufacturers Anti-AIDs Drug Product Type
Table 9. List of Global Tier 1 Anti-AIDs Drug Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Anti-AIDs Drug Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Anti-AIDs Drug Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Global Anti-AIDs Drug Revenue (US$, Mn), 2017-2022
Table 13. By Type - Global Anti-AIDs Drug Revenue (US$, Mn), 2023-2028
Table 14. By Type - Global Anti-AIDs Drug Sales (K Doses), 2017-2022
Table 15. By Type - Global Anti-AIDs Drug Sales (K Doses), 2023-2028
Table 16. By Application – Global Anti-AIDs Drug Revenue, (US$, Mn), 2021 & 2028
Table 17. By Application - Global Anti-AIDs Drug Revenue (US$, Mn), 2017-2022
Table 18. By Application - Global Anti-AIDs Drug Revenue (US$, Mn), 2023-2028
Table 19. By Application - Global Anti-AIDs Drug Sales (K Doses), 2017-2022
Table 20. By Application - Global Anti-AIDs Drug Sales (K Doses), 2023-2028
Table 21. By Region – Global Anti-AIDs Drug Revenue, (US$, Mn), 2021 VS 2028
Table 22. By Region - Global Anti-AIDs Drug Revenue (US$, Mn), 2017-2022
Table 23. By Region - Global Anti-AIDs Drug Revenue (US$, Mn), 2023-2028
Table 24. By Region - Global Anti-AIDs Drug Sales (K Doses), 2017-2022
Table 25. By Region - Global Anti-AIDs Drug Sales (K Doses), 2023-2028
Table 26. By Country - North America Anti-AIDs Drug Revenue, (US$, Mn), 2017-2022
Table 27. By Country - North America Anti-AIDs Drug Revenue, (US$, Mn), 2023-2028
Table 28. By Country - North America Anti-AIDs Drug Sales, (K Doses), 2017-2022
Table 29. By Country - North America Anti-AIDs Drug Sales, (K Doses), 2023-2028
Table 30. By Country - Europe Anti-AIDs Drug Revenue, (US$, Mn), 2017-2022
Table 31. By Country - Europe Anti-AIDs Drug Revenue, (US$, Mn), 2023-2028
Table 32. By Country - Europe Anti-AIDs Drug Sales, (K Doses), 2017-2022
Table 33. By Country - Europe Anti-AIDs Drug Sales, (K Doses), 2023-2028
Table 34. By Region - Asia Anti-AIDs Drug Revenue, (US$, Mn), 2017-2022
Table 35. By Region - Asia Anti-AIDs Drug Revenue, (US$, Mn), 2023-2028
Table 36. By Region - Asia Anti-AIDs Drug Sales, (K Doses), 2017-2022
Table 37. By Region - Asia Anti-AIDs Drug Sales, (K Doses), 2023-2028
Table 38. By Country - South America Anti-AIDs Drug Revenue, (US$, Mn), 2017-2022
Table 39. By Country - South America Anti-AIDs Drug Revenue, (US$, Mn), 2023-2028
Table 40. By Country - South America Anti-AIDs Drug Sales, (K Doses), 2017-2022
Table 41. By Country - South America Anti-AIDs Drug Sales, (K Doses), 2023-2028
Table 42. By Country - Middle East & Africa Anti-AIDs Drug Revenue, (US$, Mn), 2017-2022
Table 43. By Country - Middle East & Africa Anti-AIDs Drug Revenue, (US$, Mn), 2023-2028
Table 44. By Country - Middle East & Africa Anti-AIDs Drug Sales, (K Doses), 2017-2022
Table 45. By Country - Middle East & Africa Anti-AIDs Drug Sales, (K Doses), 2023-2028
Table 46. GSK Corporate Summary
Table 47. GSK Anti-AIDs Drug Product Offerings
Table 48. GSK Anti-AIDs Drug Sales (K Doses), Revenue (US$, Mn) and Average Price (USD/Dose) (2017-2022)
Table 49. Cipla Corporate Summary
Table 50. Cipla Anti-AIDs Drug Product Offerings
Table 51. Cipla Anti-AIDs Drug Sales (K Doses), Revenue (US$, Mn) and Average Price (USD/Dose) (2017-2022)
Table 52. MSD Corporate Summary
Table 53. MSD Anti-AIDs Drug Product Offerings
Table 54. MSD Anti-AIDs Drug Sales (K Doses), Revenue (US$, Mn) and Average Price (USD/Dose) (2017-2022)
Table 55. Gilead Sciences Corporate Summary
Table 56. Gilead Sciences Anti-AIDs Drug Product Offerings
Table 57. Gilead Sciences Anti-AIDs Drug Sales (K Doses), Revenue (US$, Mn) and Average Price (USD/Dose) (2017-2022)
Table 58. Frontier Biotechnologies Corporate Summary
Table 59. Frontier Biotechnologies Anti-AIDs Drug Product Offerings
Table 60. Frontier Biotechnologies Anti-AIDs Drug Sales (K Doses), Revenue (US$, Mn) and Average Price (USD/Dose) (2017-2022)
Table 61. Anti-AIDs Drug Production Capacity (K Doses) of Key Manufacturers in Global Market, 2020-2022 (K Doses)
Table 62. Global Anti-AIDs Drug Capacity Market Share of Key Manufacturers, 2020-2022
Table 63. Global Anti-AIDs Drug Production by Region, 2017-2022 (K Doses)
Table 64. Global Anti-AIDs Drug Production by Region, 2023-2028 (K Doses)
Table 65. Anti-AIDs Drug Market Opportunities & Trends in Global Market
Table 66. Anti-AIDs Drug Market Drivers in Global Market
Table 67. Anti-AIDs Drug Market Restraints in Global Market
Table 68. Anti-AIDs Drug Raw Materials
Table 69. Anti-AIDs Drug Raw Materials Suppliers in Global Market
Table 70. Typical Anti-AIDs Drug Downstream
Table 71. Anti-AIDs Drug Downstream Clients in Global Market
Table 72. Anti-AIDs Drug Distributors and Sales Agents in Global Market

List Of Figures

LIST OF FIGURES

Figure 1. Anti-AIDs Drug Segment by Type
Figure 2. Anti-AIDs Drug Segment by Application
Figure 3. Global Anti-AIDs Drug Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Anti-AIDs Drug Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Anti-AIDs Drug Revenue, 2017-2028 (US$, Mn)
Figure 7. Anti-AIDs Drug Sales in Global Market: 2017-2028 (K Doses)
Figure 8. The Top 3 and 5 Players Market Share by Anti-AIDs Drug Revenue in 2021
Figure 9. By Type - Global Anti-AIDs Drug Sales Market Share, 2017-2028
Figure 10. By Type - Global Anti-AIDs Drug Revenue Market Share, 2017-2028
Figure 11. By Type - Global Anti-AIDs Drug Price (USD/Dose), 2017-2028
Figure 12. By Application - Global Anti-AIDs Drug Sales Market Share, 2017-2028
Figure 13. By Application - Global Anti-AIDs Drug Revenue Market Share, 2017-2028
Figure 14. By Application - Global Anti-AIDs Drug Price (USD/Dose), 2017-2028
Figure 15. By Region - Global Anti-AIDs Drug Sales Market Share, 2017-2028
Figure 16. By Region - Global Anti-AIDs Drug Revenue Market Share, 2017-2028
Figure 17. By Country - North America Anti-AIDs Drug Revenue Market Share, 2017-2028
Figure 18. By Country - North America Anti-AIDs Drug Sales Market Share, 2017-2028
Figure 19. US Anti-AIDs Drug Revenue, (US$, Mn), 2017-2028
Figure 20. Canada Anti-AIDs Drug Revenue, (US$, Mn), 2017-2028
Figure 21. Mexico Anti-AIDs Drug Revenue, (US$, Mn), 2017-2028
Figure 22. By Country - Europe Anti-AIDs Drug Revenue Market Share, 2017-2028
Figure 23. By Country - Europe Anti-AIDs Drug Sales Market Share, 2017-2028
Figure 24. Germany Anti-AIDs Drug Revenue, (US$, Mn), 2017-2028
Figure 25. France Anti-AIDs Drug Revenue, (US$, Mn), 2017-2028
Figure 26. U.K. Anti-AIDs Drug Revenue, (US$, Mn), 2017-2028
Figure 27. Italy Anti-AIDs Drug Revenue, (US$, Mn), 2017-2028
Figure 28. Russia Anti-AIDs Drug Revenue, (US$, Mn), 2017-2028
Figure 29. Nordic Countries Anti-AIDs Drug Revenue, (US$, Mn), 2017-2028
Figure 30. Benelux Anti-AIDs Drug Revenue, (US$, Mn), 2017-2028
Figure 31. By Region - Asia Anti-AIDs Drug Revenue Market Share, 2017-2028
Figure 32. By Region - Asia Anti-AIDs Drug Sales Market Share, 2017-2028
Figure 33. China Anti-AIDs Drug Revenue, (US$, Mn), 2017-2028
Figure 34. Japan Anti-AIDs Drug Revenue, (US$, Mn), 2017-2028
Figure 35. South Korea Anti-AIDs Drug Revenue, (US$, Mn), 2017-2028
Figure 36. Southeast Asia Anti-AIDs Drug Revenue, (US$, Mn), 2017-2028
Figure 37. India Anti-AIDs Drug Revenue, (US$, Mn), 2017-2028
Figure 38. By Country - South America Anti-AIDs Drug Revenue Market Share, 2017-2028
Figure 39. By Country - South America Anti-AIDs Drug Sales Market Share, 2017-2028
Figure 40. Brazil Anti-AIDs Drug Revenue, (US$, Mn), 2017-2028
Figure 41. Argentina Anti-AIDs Drug Revenue, (US$, Mn), 2017-2028
Figure 42. By Country - Middle East & Africa Anti-AIDs Drug Revenue Market Share, 2017-2028
Figure 43. By Country - Middle East & Africa Anti-AIDs Drug Sales Market Share, 2017-2028
Figure 44. Turkey Anti-AIDs Drug Revenue, (US$, Mn), 2017-2028
Figure 45. Israel Anti-AIDs Drug Revenue, (US$, Mn), 2017-2028
Figure 46. Saudi Arabia Anti-AIDs Drug Revenue, (US$, Mn), 2017-2028
Figure 47. UAE Anti-AIDs Drug Revenue, (US$, Mn), 2017-2028
Figure 48. Global Anti-AIDs Drug Production Capacity (K Doses), 2017-2028
Figure 49. The Percentage of Production Anti-AIDs Drug by Region, 2021 VS 2028
Figure 50. Anti-AIDs Drug Industry Value Chain
Figure 51. Marketing Channels